What is it about?

In this study, during 4.5-year follow-up, we compared efficacy and safety of two different formulations of interferon- beta namely AVONEX and CINNOVEX for treatment of RRMS.

Featured Image

Why is it important?

In developing countries, the cost of treatment is of paramount importance for both patients and physicians. this study highlighted that the efficacy and safety of nationally produced interferon -beta (CINNOVEX) are not different from that of its well-known parallel product (AVONEX).

Perspectives

this article highlights the fact that nationally produced interferon-beta (CINNOVEX) is superior to AVONEX with respect to its cost for Iranian patients with RRMS

Dr Mehdi Abbasi
Shahid Beheshti University of Medical Sciences

Read the Original

This page is a summary of: A randomized double-blind trial of comparative efficacy and safety of Avonex and CinnoVex for treatment of relapsing-remitting multiple sclerosis, Neurological Sciences, August 2018, Springer Science + Business Media,
DOI: 10.1007/s10072-018-3550-8.
You can read the full text:

Read

Resources

Contributors

The following have contributed to this page